Gene · 54822
Papers2,329
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
81 to 100 of 2,329
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Myocardial ischemia/reperfusion-induced glycolysis enhances damage through TRPM7 histone lactylation. | Toxicol Appl Pharmacol | 2025 | 40796076 | PubTator, text mining | PubMed |
| The Association of Gut Microbiota With TRPM7 Genotype, Colorectal Polyps, and Magnesium. | J Nutr | 2025 | 40750038 | PubTator, text mining | PubMed |
| M6A RNA modification: focusing on non-small cell lung cancer progression, therapeutic strategies and challenges. | Front Oncol | 2025 | 40740874 | PubTator, text mining | PubMed |
| Paradoxical Inadequate Parathyroid Hormone Secretion Secondary to Severe Hypomagnesemia: A Review of the Literature. | Kidney Med | 2025 | 40740723 | PubTator, text mining | PubMed |
| TRPM7 Kinase and Mitochondrial Dysfunction in Diabetic Heart Failure With Preserved Ejection Fraction: A Molecular Entry Point to a Complex Disease. | JACC Basic Transl Sci | 2025 | 40712342 | PubTator, text mining | PubMed |
| Potential functions of TRPM2 and TRPM7 channels in the tumor microenvironment. | J Leukoc Biol | 2025 | 40632830 | PubTator, text mining | PubMed |
| The role of transient receptor potential melastatin channels in compressive force-induced contraction of primary cardiac pericytes. | Physiol Rep | 2025 | 40526043 | PubTator, text mining | PubMed |
| Correction to: Downregulation of TRPM7 suppressed migration and invasion by regulating epithelial-mesenchymal transition in prostate cancer cells. | Med Oncol | 2025 | 40445512 | PubTator, text mining | PubMed |
| Transient Receptor Potential Channels in Physiology and Pathophysiology: Special Issue. | Int J Mol Sci | 2025 | 40430100 | PubTator, text mining | PubMed |
| Invadopodia in cancer metastasis: dynamics, regulation, and targeted therapies. | J Transl Med | 2025 | 40380267 | PubTator, text mining | PubMed |
| The kinase domain of TRPM7 interacts with PAK1 and regulates pancreatic cancer cell epithelial-to-mesenchymal transition. | Cell Death Dis | 2025 | 40274768 | PubTator, text mining | PubMed |
| Application of biodegradable implants in pediatric orthopedics: shifting from absorbable polymers to biodegradable metals. | Bioact Mater | 2025 | 40256329 | PubTator, text mining | PubMed |
| Placental magnesium transport-related mRNA expression is not associated with serum magnesium in singletons and twins. | Placenta | 2025 | 40222296 | PubTator, text mining | PubMed |
| Mg2+ influx mediated by TRPM7 triggers the initiation of muscle stem cell activation. | Sci Adv | 2025 | 40184450 | PubTator, text mining | PubMed |
| Huangqi Guizhi Wuwu Decoction alleviates diabetic cardiovascular autonomic neuropathy via AMPK/TrkA/TRPM7 pathway. | J Ethnopharmacol | 2025 | 40107475 | PubTator, text mining | PubMed |
3D-printed PCL scaffolds combined with injectable sodium alginate/magnesium-doped mesoporous bioactive glass nanosphere hydrogel for meniscus regeneration: In vitro, In vivo, and multiomics-based therapeutic analyses. | Bioact Mater | 2025 | 40060143 | PubTator, text mining | PubMed |
| Author Correction: Naltriben promotes tumor growth by activating the TRPM7-mediated development of the anti-inflammatory M2 phenotype. | NPJ Precis Oncol | 2025 | 40021907 | PubTator, text mining | PubMed |
| Bioactive Inorganic Materials for Innervated Multi-Tissue Regeneration. | Adv Sci (Weinh) | 2025 | 40013907 | PubTator, text mining | PubMed |
| Molecular Mechanism of Oil-Infused Silicone Preventing Mussel Biofouling. | Research (Wash D C) | 2025 | 39995899 | PubTator, text mining | PubMed |
| TRPM7 channel activity promotes the pathogenesis of abdominal aortic aneurysms. | Nat Cardiovasc Res | 2025 | 39953276 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/54822/papers?page=5